Integra Lifesciences: Q3 Earnings Insights

Shares of Integra Lifesciences IART remained unaffected after the company reported Q3 results.

Quarterly Results

Earnings per share were up 17.65% year over year to $0.80, which beat the estimate of $0.53.

Revenue of $370,232,000 declined by 2.34% from the same period last year, which beat the estimate of $347,980,000.

Looking Ahead

Integra Lifesciences hasn't issued any earnings guidance for the time being.

Integra Lifesciences hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Oct 28, 2020

Time: 08:30 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/wzveg3um

Price Action

Company's 52-week high was at $63.23

52-week low: $34.21

Price action over last quarter: down 9.03%

Company Description

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.